Journal List > Korean J Lab Med > v.27(3) > 1011389

Chung, Chi, Cho, Jang, and Park: Bone Marrow Fibrin-Ring Granuloma: Review of 24 Cases

Abstract

Background

Fibrin-ring granuloma (FRG), which can be found in bone marrow or the liver, is a subtype of epithelioid granuloma characterized by a central fat vacuole and annular peripheral fibrinoid materials. FRG has been proven to be associated with many etiologies such as several infectious organisms (Coxiella burnett; Epstein-Barr Virus, EBV; cytomegalovirus, CMV; and hepatitis A virus), allopurinol induced hepatitis, Hodgkin's lymphoma, and peripheral T-cell lymphoma.

Methods

We retrospectively reviewed 24 patients diagnosed with FRG by bone marrow biopsy at a single institute between 1995 and 2004. We reviewed clinical symptoms and laboratory findings of the patients, classified them by etiology, and compared prognosis of each group.

Results

The most common cause of FRG was acute or chronic EBV infection. Chronic or acute EBV infection was associated with 41.4% of patients (10/24). Of the remaining patients, 33.3% (8/24) were leukemia or lymphoma patients after chemotherapy, 4.2% (1/24) was a patient with hepatic failure, and 20.8% (5/24) were diagnosed as fever of unknown origin. The most common symptom and clinical finding were fever and cytopenia. EBV-associated group comprised chronic active EBV infection, EBV-associated hemophagocytic histiocytosis, acute EBV infection, EBV-associated lymphoproliferative disease, and Langerhans' cell histiocytosis. The EBV-associated group showed a lower survival probability compared with the non-EBV group (P<0.05).

Conclusions

Patients with bone marrow fibrin ring granuloma accompanied by fever require an active workup to find out the cause of infectious agents including EBV infection particularly due to their poor prognosis.

References

1. Blanco P, Viallard JF, Parrens M, Mercie P, Pellegrin JL. Bone-marrow fibrin-ring granuloma. Lancet. 2003; 362:1224.
crossref
2. Kvasnicka HM, Thiele J. Differentiation of granulomatous lesions in the bone marrow. Pathologe. 2002; 23:465–71.
3. Okun DB, Sun NC, Tanaka KR. Bone marrow granulomas in Q fever. Am J Clin Pathol. 1979; 71:117–21.
crossref
4. Voigt JJ, Delsol G, Fabre J. Liver and bone marrow granulomas in Q fever. Gastroenterology. 1983; 84:887–8.
crossref
5. Young JF, Goulian M. Bone marrow fibrin ring granulomas and cytomegalovirus infection. Am J Clin Pathol. 1993; 99:65–8.
crossref
6. Vanderstigel M, Zafrani ES, Lejonc JL, Schaeffer A, Portos JL. Allopurinol hypersensitivity syndrome as a cause of hepatic fibrin-ring granulomas. Gastroenterology. 1986; 90:188–90.
crossref
7. Raya Sanchez JM, Arguelles HA, Brito Barroso ML, Nieto LH. Bone marrow fibrin-ring (doughnut) granulomas and peripheral T-cell lymphoma: an exceptional association. Haematologica. 2001; 86:112.
8. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol. 2000; 38:712–5.
crossref
9. Ende N, Gelpi AP. Pathologic changes noted in bone marrow in a case of Q fever. AMA Arch Internal Med. 1957; 100:793–6.
10. Ruel M, Sevestre H, Henry-Biabaud E, Courouce AM, Capron JP, Erlinger S. Fibrin ring granulomas in hepatitis A. Dig Dis Sci. 1992; 37:1915–7.
crossref
11. Nenert M, Mavier P, Dubuc N, Deforges L, Zafrani ES. Epstein-Barr virus infection and hepatic fibrin-ring granulomas. Hum Pathol. 1988; 19:608–10.
crossref
12. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000; 343:481–92.
crossref
13. Oh SH, Lee YA, Moon WY, Ko TS, Park YS, Moon HN, et al. Prevalence of Epstein-Barr Vvirus (EBV) antibody in Korean children. J Korean Pediatr Soc. 1994; 37:804–11.
14. Fiala M, Colodro I, Talbert W, Ellis R, Chatterjee S. Bone marrow granulomas in mononucleosis. Postgrad Med J. 1987; 63:277–9.
crossref
15. Straus SE. The chronic mononucleosis syndrome. J Infect Dis. 1988; 157:405–12.
crossref
16. Kang ES, Gong GY, Chi HS. A case of fibrin-ring granuloma in bone marrow and liver associated with Epstein-Barr virus infection. Korean J Clin Pathol. 1995; 15:178–82.
17. de Bayser L, Roblot P, Ramassamy A, Silvain C, Levillain P, Becq-Giraudon B. Hepatic fibrin-ring granulomas in giant cell arteritis. Gastroenterology. 1993; 105:272–3.
crossref
18. Delsol G, Pellegrin M, Voigt JJ, Fabre J. Diagnostic value of granuloma with fibrinoid ring. Am J Clin Pathol. 1980; 73:289.
crossref
19. Rexroth G, Rosch W, Altmannsberger M. Bone marrow granulomatosis in Q-fever. Med Klin (Munich). 2000; 95:404–8.
20. Srigley JR, Vellend H, Palmer N, Phillips MJ, Geddie WR, Van Nostrand AW, et al. Q-fever. The liver and bone marrow pathology. Am J Surg Pathol. 1985; 9:752–8.

Fig. 1.
(A) Multiple fibrin-ring granulomas in UPN 5 (BM clot section, Hematoxylin-Eosin stain, ×400). EBV PCR with BM sample revealed positive. (B) Fibrin-ring granulomas in UPN 10. Serial result of real-time EBV quantitative PCR presented 15,720 copies/mL at the diagnosis of FRG and decreased to 2,490 copies/mL after 10 days (BM biopsy specimen, Hematoxylin-Eosin stain, ×400). (C) Masson's trichrome stain of fibrin-ring granulomas in UPN 10 (BM biopsy specimen, trichrome stain, ×400).
kjlm-27-182f1.tif
Fig. 2.
Kaplan-Meier survival curves of patients. EBV positive group shows a significantly low survival rate. The median survival of EBV positive group is 1.4 months (mean=2.0 months) and that of negative group is 11.8 months (mean=50.7 months).
Abbreviation: UPN, unique patient number.
kjlm-27-182f2.tif
Table 1.
Clinical and laboratory data of patients
Group UPN Age/Sex Diagnosis Clinical feature
Laboratory data
Outcome
Fever Hepatomegaly Splenomegaly LAP WBC (/μL) Hb (g/dL) PLT (× 103/μL AST (IU/L) ALT (IU/L) LDH (IU/L)
1 5 37/M CAEBV + + 3,700 9.9 179 73 140 NT Dead
  7 41/M CAEBV + + + 4,200 16.5 121 127 250 NT Dead
  3 46/M CAEBV + + + 16,300 9.9 246 38 19 16,170 Dead
  4 62/M CAEBV + + 10,400 9.8 129 46 16 738 Dead
  2 3/M EBV-HLH + + + 2,400 9.9 186 231 222 NT Dead
  1 34/M EBV-HLH + + + + 1,000 7.6 21 508 149 3,136 Dead
  8 50/M Acute EBV + + 5,800 12.1 184 314 226 4.659 Alive
  6 8/F LCH + + + 5,600 12.1 124 113 85 NT Alive
  9 36/M EBV associated LPD + + + 18,600 5.6 326 142 200 1,563 Dead
  10 35/M T-cell lymphoma on skin, EBV ISH+ + + + 2,100 10.2 95 174 166 346 Dead
2 11 40/M T-cell lymphoma + 7,000 10.0 458 39 47 847 Alive
  15 50/M T-cell lymphoma + + 1,800 12.1 153 74 48 1.458 Dead
  12 55/M T-cell lymphoma + + 600 7.6 14 274 117 2.926 Alive
  18 60/M T-cell lymphoma + + + + 19,100 9.8 230 28 35 534 Alive
  14 69/M Hodgkin's lymphoma + + + + 3,300 10.5 66 68 48 1.941 Alive
  16 52/F AML M1 9,800 10.9 468 54 171 332 Alive
  13 46/M AML M2 + + 5,400 8.3 10 39 105 605 Alive
  17 53/F ALL L2 1,000 8.7 43 15 33 448 Dead
3 19 33/F Hepatic failure + + + + 1,800 13.5 179 162 131 2,134 Dead
4 23 36/M FUO + 7,500 11.5 210 29 51 898 Alive
  20 38/M FUO + + 6,000 12.1 248 70 45 NT Dead
  22 59/M FUO + 16,100 13.2 534 31 44 294 Alive
  21 67/M FUO + 6,000 11.4 130 38 30 NT Alive
  24 76/M FUO + 21,000 12.3 309 19 19 713 Alive

Abbreviations: UPN, unique patient number; LAP, lymphadenopathry; NT, not tested; CAEBV, chronic active EBV infection; EBV-HLH, EBV associated hemophagocytic lymphohistiocytosis; LCH, Langerhans' cell histiocytosis; LPD, Lymphoproliferative disease; ISH, in situ hybridization; FUO, fever of unknown origin.

Table 2.
Four groups of patients with fibrin-granuloma according to their etiology
Group N of patient (n) % of patient
I Acute or Chronic EBV infection 10 41.7
II Leukemia or lymphoma after chemotherapy 8 33.3
III Hepatic failure 1 4.2
IV FUO 5 20.8
Total 24 100.0

Abbreviations: See Table 1.

Table 3.
Review of the literature: bone marrow fibrin-ring granuloma
Diagnosis N of patient Specimen Author Year
Hodgkin's lymphoma 1 BM Delsol et al.[18] 1980
Acute EBV infection 1 BM Voigt et al.[4] 1983
Acute EBV infection 1 BM Blanco P et al.[1] 2003
EBV-HLH 1 BM and liver Kang et al.[16] 1995
After drug therapy of Lyme disease 1 BM Kvasnicka HM et al.[2] 2002
Peripheral T-cell lymphoma 1 BM Raya Sanchez JM et al.[7] 2001
Q-fever 1 BM Rexroth G et al.[19] 2000
CMV infection 2 BM Young JF et al.[5] 1993
Q-fever 4 BM Srigley JR et al.[20] 1985

Abbreviations: See Table 1.

TOOLS
Similar articles